Osivax announces first participant vaccinated in phase 2a clinical booster trial of influenza vaccine candidate OVX836: Lyon, France Saturday, November 16, 2024, 14:00 Hrs [IST] O ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback